Sandy Ferber

591 total citations
9 papers, 277 citations indexed

About

Sandy Ferber is a scholar working on Oncology, Biotechnology and Immunology. According to data from OpenAlex, Sandy Ferber has authored 9 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Biotechnology and 2 papers in Immunology. Recurrent topics in Sandy Ferber's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Sandy Ferber is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Sandy Ferber collaborates with scholars based in United States. Sandy Ferber's co-authors include Kim Margolin, John A. Thompson, William McCulloch, Walter M. Stadler, Douglas Kling, Danielle Curcio, Michael H. Davidson, Judith Johnson, Elliot Offman and Dirk G. Brockstedt and has published in prestigious journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Vascular Health and Risk Management.

In The Last Decade

Sandy Ferber

9 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandy Ferber United States	7	133	110	53	40	36	9	277
Von G. Samedi United States	9	95 0.7×	106 1.0×	19 0.4×	86 2.1×	34 0.9×	19	322
Yolanda Chico Spain	12	152 1.1×	45 0.4×	25 0.5×	49 1.2×	63 1.8×	24	332
Marilidia Piglionica Italy	9	110 0.8×	61 0.6×	21 0.4×	16 0.4×	67 1.9×	20	249
Melinde Wijers Netherlands	6	95 0.7×	34 0.3×	37 0.7×	22 0.6×	101 2.8×	7	256
Makoto Sugimori Japan	11	108 0.8×	95 0.9×	17 0.3×	34 0.8×	71 2.0×	23	303
Nolan Bick United States	7	100 0.8×	47 0.4×	43 0.8×	12 0.3×	62 1.7×	8	258
Bing Zhou China	7	185 1.4×	41 0.4×	52 1.0×	37 0.9×	21 0.6×	19	320
Yuka Takezaki Japan	10	150 1.1×	74 0.7×	11 0.2×	24 0.6×	61 1.7×	17	327
Thorsten Koch Germany	6	58 0.4×	55 0.5×	11 0.2×	36 0.9×	25 0.7×	8	213
Amin Esmaeilniakooshkghazi United States	7	207 1.6×	33 0.3×	19 0.4×	42 1.1×	21 0.6×	9	285

Countries citing papers authored by Sandy Ferber

Since Specialization

Citations

This map shows the geographic impact of Sandy Ferber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Ferber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Ferber more than expected).

Fields of papers citing papers by Sandy Ferber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy Ferber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Ferber. The network helps show where Sandy Ferber may publish in the future.

Co-authorship network of co-authors of Sandy Ferber

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Ferber. A scholar is included among the top collaborators of Sandy Ferber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Ferber. Sandy Ferber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Le, Dung T., Andrew H. Ko, Zev A. Wainberg, et al.. (2017). Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).. Journal of Clinical Oncology. 35(4_suppl). 345–345. 39 indexed citations

Le, Dung T., Todd S. Crocenzi, Jennifer N. Uram, et al.. (2016). Randomized phase II study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).. Journal of Clinical Oncology. 34(4_suppl). TPS486–TPS486. 10 indexed citations

Le, Dung T., Todd S. Crocenzi, Jennifer N. Uram, et al.. (2016). Randomized phase 2 study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).. Journal of Clinical Oncology. 34(15_suppl). TPS4153–TPS4153. 1 indexed citations

Le, Dung T., Todd S. Crocenzi, Eric R. Lutz, et al.. (2015). Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR). Journal for ImmunoTherapy of Cancer. 3(S2). 9 indexed citations

Le, Dung T., Andrea Wang‐Gillam, Vincent J. Picozzi, et al.. (2015). A phase IIb, randomized, controlled, multicenter, open-label study of the efficacy and immune response of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).. Journal of Clinical Oncology. 33(3_suppl). TPS489–TPS489. 2 indexed citations

Whiting, Chan C., Eric R. Lutz, Nitya Nair, et al.. (2015). Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.. Journal of Clinical Oncology. 33(3_suppl). 261–261. 9 indexed citations

Le, Dung T., Todd S. Crocenzi, Jennifer N. Uram, et al.. (2015). Randomized phase II study of the safety, efficacy, and immune response of GVAX pancreas vaccine (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).. Journal of Clinical Oncology. 33(15_suppl). TPS4148–TPS4148. 8 indexed citations

Offman, Elliot, Sandy Ferber, Judith Johnson, et al.. (2013). Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study. Vascular Health and Risk Management. 9. 563–563. 71 indexed citations

Stadler, Walter M., Kim Margolin, Sandy Ferber, William McCulloch, & John A. Thompson. (2006). A Phase II Study of Depsipeptide in Refractory Metastatic Renal Cell Cancer. Clinical Genitourinary Cancer. 5(1). 57–60. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact